Healthcare Services

Hepatitis D Market Forecast: Demand Trends and Growth Insights

April 22, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Hepatitis D Market In 2026, And How Will Its Value Evolve By 2030?

The hepatitis d market has experienced steady growth in recent years. Forecasts indicate it will expand from $0.76 billion in 2025 to $0.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.4%. Historically, this growth is a result of improved hepatitis B screening coverage, increased recognition of HDV severity, expanded diagnostic capabilities, a rise in referrals to specialty centers, and the availability of targeted therapies.

The hepatitis d market size is anticipated to undergo steady expansion over the next few years. It is forecast to reach $0.93 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.1%. This growth during the forecast period can be attributed to several factors, including increasing research into novel HDV treatments, a rising focus on combination antiviral therapies, the expansion of vaccination-linked prevention strategies, growing awareness within high-risk populations, and increased investments in rare liver disease research. Furthermore, major trends projected for this period encompass an increasing focus on the early detection of co-infections, the rising use of advanced serologic testing, a growing demand for specialized treatment protocols, the expansion of hospital-based disease management, and an enhanced focus on disease awareness.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/hepatitis-d-global-market-report

Which Drivers Are Supporting The Hepatitis D Market Growth?

The rising occurrence of hepatitis B is anticipated to fuel expansion within the hepatitis D market in the future. Hepatitis B is characterized as a viral infection targeting the liver, manifesting symptoms like jaundice, weariness, and stomach discomfort, potentially progressing to chronic liver disease or liver cancer if not addressed. The growth in hepatitis B instances stems from factors such as unprotected sexual activity, needle sharing, transmission from mother to child during birth, and inadequate vaccination rates in certain areas. Hepatitis D requires the hepatitis B virus for its reproduction, utilizing the hepatitis B surface antigen to infiltrate liver cells, thereby establishing co-infection of both viruses as a crucial element in the advancement of liver disease. As an illustration, in April 2025, data from the US Department of Health and Human Services indicated 17,650 newly reported chronic hepatitis B cases and 1,769 hepatitis B-related fatalities were recorded during 2023. Consequently, the escalating incidence of hepatitis B is propelling the expansion of the hepatitis D market.

How Is The Hepatitis D Market Broken Down By Segment Categories?

The hepatitis d market covered in this report is segmented –

1) By Type: Acute, Chronic

2) By Diagnosis: Blood Tests, Elastography, Liver Biopsy, Serologic Testing, Other Diagnosis

3) By Distribution Channel: Hospital pharmacies, Retail pharmacies

4) By End-Users: Clinic, Hospital, Other End Users

Subsegments:

1) By Acute: Self-limiting Acute Hepatitis D, Severe Acute Hepatitis D

2) By Chronic: Compensated Chronic Hepatitis D, Decompensated Chronic Hepatitis D

Which Trends Are Expected To Impact The Hepatitis D Market?

Prominent companies active in the hepatitis D market are concentrating on devising innovative solutions, like RNA-targeted antiviral therapy, to elevate treatment outcomes and fulfill pressing medical needs in chronic hepatitis D infection. RNA-targeted antiviral therapy denotes a therapeutic method that directly targets the RNA of a virus to suppress its replication, disrupt viral protein synthesis, or silence viral genes, thereby diminishing viral load and managing the infection. For example, in December 2024, Vir Biotechnology Inc., a US-based biotechnology company, secured both the U.S. Food and Drug Administration (FDA) Breakthrough Therapy designation and the European Medicines Agency (EMA) Priority Medicines (PRIME) designation for its combination therapy involving tobevibart and elebsiran for the treatment of chronic hepatitis delta (CHD).

Which Players Are Present In The Hepatitis D Market Space?

Major companies operating in the hepatitis d market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bristol-Myers Squibb Company, Abbott Laboratories, GSK plc, Gilead Sciences Inc., Viatris Inc., VBI Vaccines Inc., Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Dynavax Technologies Corporation, Echosens S.A., Arbutus Biopharma Corporation, PROBIOMED SA de CV, Assembly Biosciences Inc., Replicor Inc., Eiger BioPharmaceuticals Inc., Bluejay Therapeutics Inc., Janssen Pharmaceuticals Inc., Transgene SA, Vir Biotechnology Inc., Biorex Diagnostics Ltd.

Get The Full Hepatitis D Market Report:

https://www.thebusinessresearchcompany.com/report/hepatitis-d-global-market-report

Which Region Accounts For The Largest Portion Of The Hepatitis D Market?

North America was the largest region in the hepatitis D market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis d market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Hepatitis D Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/hepatitis-d-global-market-report

Browse Through More Reports Similar to the Global Hepatitis D Market 2026, By The Business Research Company

Hepatitis C Market Report 2026

https://www.thebusinessresearchcompany.com/report/hepatitis-c-global-market-report

Viral Hepatitis Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

Vitamin D Market Report 2026

https://www.thebusinessresearchcompany.com/report/vitamin-d-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795